Compositions, systems and methods of removing ammonia from fish storage systems are presented. A chemical water conditioner comprised of sodium formaldehyde bisulfite, cornstarch, dye and alcohol was found to have a high ammonia removal efficiency in seawater. A combination of this chemical water conditioner with modified chabazite and phosphate buffer exhibited high ammonia removal efficiency in both seawater and freshwater.

The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.

The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.

Crystalline molecular sieves and their synthesis using quaternary N-methyl-diisoalkylammonium cations as organic structure directing agents are disclosed. The structure directing agent has the following structure (1):

##STR00001##

in which R.sup.1 is selected from hydrogen, a methyl group, an ethyl group, a propyl group, and a hydroxymethyl group; and R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are independently selected from a methyl group, an ethyl group, and a propyl group.

Crystalline molecular sieves and their synthesis using quaternary N-methyl-diisoalkylammonium cations as organic structure directing agents are disclosed. The structure directing agent has the following structure (1):

##STR00001##

in which R.sup.1 is selected from hydrogen, a methyl group, an ethyl group, a propyl group, and a hydroxymethyl group; and R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are independently selected from a methyl group, an ethyl group, and a propyl group.

Crystalline molecular sieves and their synthesis using quaternary N-methyl-diisoalkylammonium cations as organic structure directing agents are disclosed. The structure directing agent has the following structure (1): ##STR00001##
in which R.sup.1 is selected from hydrogen, a methyl group, an ethyl group, a propyl group, and a hydroxymethyl group; and R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are independently selected from a methyl group, an ethyl group, and a propyl group.

Crystalline molecular sieves and their synthesis using quaternary N-methyl-diisoalkylammonium cations as organic structure directing agents are disclosed. The structure directing agent has the following structure (1): ##STR00001##
in which R.sup.1 is selected from hydrogen, a methyl group, an ethyl group, a propyl group, and a hydroxymethyl group; and R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are independently selected from a methyl group, an ethyl group, and a propyl group.

The present invention relates to a method for reducing the amount of CO.sub.2 in a carbon dioxide-containing source by using a regeneratable ion exchange material.

The present invention relates to a method for reducing the amount of CO.sub.2 in a carbon dioxide-containing source by using a regeneratable ion exchange material.

The present invention relates to novel calcium-containing microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without removing calcium from the patient's body. Also disclosed are methods of using calcium-free or low calcium microporous zirconium silicate compositions for the treatment of hyperkalemia in patients also suffering from hypercalcemia.